• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Juno Lighting

Juno Lighting

  1. All
  2. Morningstar Articles
  3. 3rd Party
  4. Investing
  1. Celgene Drug Misses Secondary Endpoint in One of Its Lymphoma Trials

    Celgene Drug Misses Secondary Endpoint in One of Its Lymphoma Trials

  2. INVESTOR ALERT: Investigation of Juno Therapeutics, Inc. Announced by Law Offices of Howard G. Smith

    INVESTOR ALERT: Investigation of Juno Therapeutics, Inc. Announced by Law Offices of Howard G. Smith

  3. Juno Shares Plunge as Drug Trial Placed on Hold After Patient Deaths

    Juno Shares Plunge as Drug Trial Placed on Hold After Patient Deaths

  4. Glancy Prongay & Murray Commences Investigation on Behalf of Juno Therapeutics, Inc. Investors

    Glancy Prongay & Murray Commences Investigation on Behalf of Juno Therapeutics, Inc. Investors

  5. INVESTOR NOTICE: Khang & Khang LLP Announces an Investigation of Juno Therapeutics Inc. and Reminds Investors With Losses to Contact the Firm

    INVESTOR NOTICE: Khang & Khang LLP Announces an Investigation of Juno Therapeutics Inc. and Reminds Investors With Losses to Contact the Firm

  6. Correction to Juno to Resume Clinical Trial Article

    Correction to Juno to Resume Clinical Trial Article

  7. Correction to Juno to Resume Clinical Trial Article

    Correction to Juno to Resume Clinical Trial Article

  8. UPDATE: 'Lights Out' producer Lawrence Grey on proving Hollywood wrong

    UPDATE: 'Lights Out' producer Lawrence Grey on proving Hollywood wrong

  9. 'Lights Out' producer Lawrence Grey on proving Hollywood wrong

    'Lights Out' producer Lawrence Grey on proving Hollywood wrong

  10. Pumped Up: Renewables Growth Revives Old Energy-Storage Method

    Pumped Up: Renewables Growth Revives Old Energy-Storage Method

123
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.